<code id='7A98863F56'></code><style id='7A98863F56'></style>
    • <acronym id='7A98863F56'></acronym>
      <center id='7A98863F56'><center id='7A98863F56'><tfoot id='7A98863F56'></tfoot></center><abbr id='7A98863F56'><dir id='7A98863F56'><tfoot id='7A98863F56'></tfoot><noframes id='7A98863F56'>

    • <optgroup id='7A98863F56'><strike id='7A98863F56'><sup id='7A98863F56'></sup></strike><code id='7A98863F56'></code></optgroup>
        1. <b id='7A98863F56'><label id='7A98863F56'><select id='7A98863F56'><dt id='7A98863F56'><span id='7A98863F56'></span></dt></select></label></b><u id='7A98863F56'></u>
          <i id='7A98863F56'><strike id='7A98863F56'><tt id='7A98863F56'><pre id='7A98863F56'></pre></tt></strike></i>

          knowledge

          knowledge

          author:entertainment    Page View:4772
          Adobe

          UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to more seniors getting care, a spike in demand for behavioral health services, and an influx of members with higher health needs.

          “Those three elements, the senior trend piece, the behavioral piece, and then the effects of the strong growth is really what explains what’s going on,” UnitedHealth Group CEO Andrew Witty said on the company’s earnings call on Friday. “We’ll continue to lean into that growth very assertively.”

          advertisement

          Minnetonka, Minn.-based UnitedHealth Group’s Optum segment, which includes its provider arm, its pharmacy benefit manager, and its data and technology arm, reported an operating margin of 6.6% in the quarter ended June 30, compared with 7.3% in the prior-year period. Leaders said the decline was within its provider arm, Optum Health.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          FDA rejects Alnylam's heart disease treatment over insufficient data
          FDA rejects Alnylam's heart disease treatment over insufficient data

          KristofferTripplaar/SipaUSA/APTheFoodandDrugAdministrationrejectedanAlnylamPharmaceuticals’therapyfo

          read more
          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

          FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

          read more

          Readout Newsletter: Biotech news, including Moderna's Covid vaccine

          RONNYHARTMANN/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup tog